Spiro Medical announced that it closed a $67 million Series A equity financing to support its neuromodulation system.
Irvine, California-based Spiro develops a first-of-its-kind pulmonary...
Surgerii Robotics has closed $100 million in Series D financing.
The Beijing-based company said last month that it will use the funding to market its...
Biobeat Technologies, developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment...
Ultromics, a pioneer in AI-driven cardiology solutions, today announced an investment from the American Heart Association’s Go Red for Women Venture Fund, a fund...
Olympus Corporation has committed $150m to a new venture capital (VC) fund, aiming to deploy the capital to promising medtech startups in the gastrointestinal...
Subsense, a developer of non-surgical invasive, nanoparticle-based brain-computer interfaces (BCIs), has added $10 million in new capital following positive early breakthroughs, bringing total funding...
Impulse Dynamics announced that it raised more than $158 million in financing to support its heart failure treatment technology.
New institutional investors, including Sands Capital...
Saluda Medical announced that it raised $150 million through an initial public offering on the Australian Securities Exchange (ASX).
Minneapolis-based Saluda raised A$230.8 million through...
Mirai Medical, the lead applicant and coordinating partner, has been awarded €7.2M under the Disruptive Technologies Innovation Fund (DTIF) Call 7 for PIONEER -...